David A. Wolk, MD

Neurology
Accepting new patients
Sees patients age 65 and up
Penn Memory Center
Schedule onlineCall 215-662-7810
Headshot of David A. Wolk, MD
Penn Medicine Provider

About me

  • Division Chair, Cognitive Disorders
  • Co-Director, Penn Memory Center
  • Professor of Neurology

My education and training

  • Medical School: Johns Hopkins University
  • Residency: University of Pennsylvania Health System
  • Fellowship: Mass General Brigham Healthcare Center - Chestnut Hill

Spoken languages

English
English

Reviews

Average Rating

147 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
he explained details so i can grasp my condition.
Anonymous
April 2026
dr. wolk is so kind and knowledgeable
Anonymous
March 2026
gave details about medication he prescribed.
Anonymous
February 2026
i respect Dr. Wolk's knowledge, experience and advice given.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Wolk is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Wolk DA, Mancuso L, Kliot D, Arnold SE, Dickerson BC Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD. , Neuropsychologia, 51(6): 2013,1094-102

Wolk DA, Price JC, Madeira C, Saxton JA, Snitz BE, Lopez OL, Mathis CA, Klunk WE, Dekosky ST Amyloid imaging in dementias with atypical presentation. , Alzheimer's & Dementia, 8(5): 2012,389-98

Pluta J, Yushkevich P, Das S, Wolk D In vivo Analysis of Hippocampal Subfield Atrophy in Mild Cognitive Impairment via Semi-Automatic Segmentation of T2-Weighted MRI. , Journal of Alzheimer's Disease, 31(1): 2012,85-99

Dickerson BC, Wolk DA MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. , Neurology, 78(2): 2011,84-90

Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, Aizenstein HJ, Cohen AD, Weissfeld LA, Mathis CA, Klunk WE, DeKosky ST Amyloid imaging in mild cognitive impairment subtypes. , Annals of Neurology, 65(5): 2009,557-68

Wolk DA, Dunfee KL, Dickerson BC, Aizenstein HJ, Dekosky ST A medial temporal lobe division of labor: Insights from memory in aging and early Alzheimer disease. , Hippocampus, 21(5): 2010,461-6

Wolk DA, Dickerson BC Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. , Proceedings of the National Academy of Sciences of the United States of America, 107(22): 2010,10256-61

Wolk DA, Dickerson BC Fractionating verbal episodic memory in Alzheimer's disease. , NeuroImage, 54(2): 2010,1530-9